Most Recent Articles by James Nam
Younger age and higher body mass index may be positive predictors of progression-free survival in patients with squamous cell carcinoma of the lung.
Adjuvant chemotherapy administered prior to, rather than concurrently with, radiotherapy improves survival outcomes among patients with NSCLC.
More than 50% of patients report experiencing cancer-related fatigue throughout the disease process.
Results of two phase 3 studies found that nivolumab provided superior overall survival vs docetaxel in people with non-small cell lung cancer.
Trial results provided strong evidence against the use of anticoagulant low molecular weight heparin in SCLC.